Total planned funding: $796,901,439
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $796,901,439 |
Organizational Types
NGO | $253,703,326 |
Private Contractor | $225,239,182 |
Unknown | $94,354,583 |
Own Agency | $76,330,964 |
University | $63,989,248 |
Implementing Agency | $55,067,890 |
FBO | $15,441,930 |
Other USG Agency | $7,848,000 |
Multi-lateral Agency | $3,726,316 |
Host Country Government Agency | $1,200,000 |
Program Areas
Treatment | $303,313,001 |
Prevention | $179,414,708 |
Care | $157,621,631 |
Governance and Systems | $56,129,093 |
Testing | $54,092,377 |
Management and Operations | $46,330,629 |
Budget Codes
HTXS: Treatment: Adult Treatment | $172,707,845 |
HTXD: Treatment: ARV Drugs | $120,430,758 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $102,221,681 |
HKID: Care: Orphans and Vulnerable Children | $94,135,782 |
HVCT: Testing: HIV Testing and Counseling | $54,092,377 |
HVMS: Management and Operations | $46,330,629 |
HVOP: Sexual Prevention: Other Sexual Prevention | $37,172,281 |
OHSS: Health Systems Strengthening | $29,714,197 |
HBHC: Care: Adult Care and Support | $28,460,596 |
HVTB: Care: TB/HIV | $25,399,737 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $19,510,608 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $18,685,138 |
HVSI: Strategic Information | $16,837,880 |
PDTX: Treatment: Pediatric Treatment | $10,174,398 |
PDCS: Care: Pediatric Care and Support | $9,625,516 |
HLAB: Laboratory Infrastructure | $9,577,016 |
HMBL: Biomedical Prevention: Blood Safety | $1,625,000 |
HMIN: Biomedical Prevention: Injection Safety | $200,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Chemonics International:
$140,616,636
Countries/Regions
Not Available:
$92,248,006
Countries/Regions
University of Washington:
$89,892,643
Countries/Regions